Search Frames
Search No frames
PathWeb Home
©
Feed Back
About
High power view of a deposit of multiple myeloma in bone
Click on Image to Enlarge it
High power view of a deposit of multiple myeloma in bone

A higher power view of a deposit of malignant melanoma in bone marrow.
Some of the typical, mature adipocytes of bone marrow are seen in this field.
Most of the other cells in this image however, resemble each other.
A typical cell can be seen at the tip of the black pointer.
It is a large cell, with a nucleus that is placed at one end of the cell.
The cytoplasm is abundant and stains blue (ie. basophilic).
A paler relatively understained area is seen near the nucleus.
These features typify a plasma cell.
Careful examination of this field reveals that most of the cells in this field resemble that cell.
Malignant melanoma is a tumor of plasma cells that arises usually in the bone marrow.
(Description By:T.V.Rajan, M.D. )
(Image Contrib. by:T.V.Rajan, M.D. UCHC )
Myeloma
Etiology

Unknown.
Pathogenesis

Clinically, myeloma presents either because of the local effects of tumor, or by the effects of the paraprotein synthesis.
Local effects include bone pain and pathological fractures.
In addition, the replacement of the marrow by the tumor can result in anemia.
Reduction in white blood cell formation by the marrow can result in an increase in the frequency and severity of infections.
The paraprotein may result in hyperviscosity symptoms (lethargy, abnormal bleeding).
The paraprotein also results in increased turnover of normal serum immunoglobulin, so that antibody mediated defence against infectious agents is impaired.
The paraprotein effects also include symptoms due to excretion of the protein in the kidney, followed by renal damage due to cast formation in the tubules.
Amyloid deposition due to the light chains is a frequent complication of multiple myeloma.
The lytic lesion is believed to be due to activation of osteoclasts by cytokines liberated by the plasma cells. These cytokines include IL-1 and TGF-beta.
IL6 may be produced primarily by stromal cells, activated by the plasma cells.
IL6 levels are used to measure progress of the tumor.,
Epidemiology

The tumor primarily affects individuals in the sixth and seventh decades of life.
Males and females are approximately equally affected.
General Gross Description

Myeloma, also known as multiple myeloma is a malignant tumor of plasma cell origin.
Grossly, myeloma is typified by multiple round deposits in various bones and soft tissues of the body.
These deposits are typically soft, gelatinous tan-white masses that are sharply demarcated.
The most frequently affected is the spine, followed by skull, pelvis, lung bones.
General Microscopic Description

Microscopically, lesion is characterized by plasma cells, which may look like normal plasma cells, or may show various levels of atypia.
Clinical Correlation

Characteristic of multiple myeloma is the presence of an abnormal, monoclonal antibody peak on serum electrophoresis.
In some instances, the plasma cells do not make complete immunoglobulin molecules. In such cases, the light chains made can be excreted in measurable quanitities in urine as Bence Jones protein.
X-ray of affected bone shows characteristic sharply defined "punched out" lesions that are purely lytic.
The prognosis is dismal, with few, if any, survivors at five years.
References

Cotran RS, Kumar V, Robbins SL: Robbins Pathologic Basis of Disease. 5th edition. Philadelphia, W.B. Saunders, 1994, pp. 663.
Myeloma
Synopsis by: T.V. Rajan M.D. Ph.D. (T1X500M97303)[80]
Search Medline at National Library of Medicine
Please be patient during transfer. Medline will open in a new window. To return, close the Medline Window
Search Frames
Search No frames
PathWeb Home
©
Feed Back
About